ClinicalTrials.Veeva

Menu

Improve SCA Bridge Study

Medtronic logo

Medtronic

Status

Completed

Conditions

Sudden Cardiac Arrest
Acute Myocardial Infarction

Treatments

Behavioral: Non-Referred group
Behavioral: EP referred group

Study type

Observational

Funder types

Industry

Identifiers

NCT03715790
MDT18019

Details and patient eligibility

About

The purpose of the Improve SCA Bridge study is to characterize the care pathway flow of post-acute myocardial infarction (MI) patients as a result of standard assessments of left ventricular ejection fraction (LVEF) in the acute phase (≤14 days post- acute MI) and chronic phase (≥40-90 days post-acute MI).

Full description

To determine how many patients are referred for sudden cardiac death (SCD) risk stratification and management, indicated for implantable cardioverter defibrillator (ICD), or cardiac resynchronization therapy- defibrillator (CRT-D) implant, and how many receive such devices within 12 months of experiencing an MI.

Enrollment

1,491 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 and above (or meet age requirements per local law)
  • Patients who have an acute Myocardial Infarction (MI) (STEMI or Non-STEMI) ≤ 30 days of study enrollment and have a LVEF <50% measurement ≤ 14 days post-acute MI
  • Willing and able to give valid Informed Consent

Exclusion criteria

  • Patient has previously received or currently implanted with an ICD or CRT-D
  • Patient has any contraindication for ICD/CRT-D
  • Patient has a life expectancy of less than 12 months
  • Patient who has had an EP referral within the last 12 months
  • Any exclusion criteria required by local law (e.g. pregnancy, breast feeding etc.)
  • Patient is unable (e.g. mental disorder) or unwilling to be compliant with the responsibilities as specified in the informed consent form.
  • Patient is enrolled in a concurrent study that has not been approved for concurrent enrollment by the Medtronic Clinical Trial Leader

Trial design

1,491 participants in 2 patient groups

EP Referred Group
Description:
Subjects with EF ≤ 40% or meeting one of the referral criteria
Treatment:
Behavioral: EP referred group
Non-Referred Group
Description:
Subjects with 40%\< EF \<50%.
Treatment:
Behavioral: Non-Referred group

Trial documents
2

Trial contacts and locations

52

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems